Mutations of Serine 236−237 and Tyrosine 302 Residues in the Human Lipoxin A4 Receptor Intracellular Domains Result in Sustained Signaling
- 13 October 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 39 (44) , 13551-13557
- https://doi.org/10.1021/bi001196i
Abstract
Lipoxin A4 (LXA4) is a potent negative modulator of the inflammatory response. The antiinflammatory activities of LXA4, such as inhibition of agonist-induced polymorphonuclear cell (PMN) chemotaxis and upregulation of β-2 integrins, require the expression of a G-protein-coupled, high-affinity LXA4 receptor (LXA4R). We now report that stimulation of PMN with proinflammatory agonist N-formyl peptides (FMLP), calcium ionophore A23187, or phorbol mirystate acetate (PMA) is followed by marked downregulation of LXA4 binding (Bmax decrease of ∼45%) and decreased activation of phospholipases A2 (PLA2) and D (PLD). Elucidation of the mechanisms underlying these effects was addressed by structure−function analyses of the intracellular domains of LXA4R. Mutant molecule, S236/S237 → A/G (LXA4Rpk) and Y302 → F (LXA4Rtk) were obtained by site-directed mutagenesis to yield receptors lacking the putative targets for serine/threonine kinase- or tyrosine kinase-dependent phosphorylation. Expression of wild-type and mutated LXA4R sequences in CHO and HL-60 cells was used to examine LXA4 ligand−receptor interactions and signal transduction events. Results indicated that cells expressing LXA4Rpk or LXA4Rtk displayed sustained activation of PLA2 and PLD in contrast to the transient ones obtained with LXA4Rwt (peak activation at 2−3 min). Moreover, inhibition of LXA4-dependent PLA2 activity by PMA in LXA4Rwt transfected CHO cells was not observed in cells expressing LXA4Rpk. Phosphopeptide immunoblotting revealed that the functional differences between wild-type and mutant LXA4 receptors are accompanied by distinct changes in the receptor protein phosphorylation pattern. Further characterization of these and related LXA4R intracellular domains will help to better understand specific events that regulate the antiinflammatory activities of LXA4.Keywords
This publication has 12 references indexed in Scilit:
- Lipoxin A4 Inhibits IL-1β-Induced IL-6, IL-8, and Matrix Metalloproteinase-3 Production in Human Synovial Fibroblasts and Enhances Synthesis of Tissue Inhibitors of MetalloproteinasesThe Journal of Immunology, 2000
- Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusionJournal of Clinical Investigation, 1999
- Lipoxin (LX)A4 and Aspirin-triggered 15-epi-LXA4 Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine AxisThe Journal of Experimental Medicine, 1999
- G PROTEIN–COUPLED RECEPTOR KINASESAnnual Review of Biochemistry, 1998
- Aspirin-triggered 15-Epi-Lipoxin A4 (LXA4) and LXA4 Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory ReceptorsThe Journal of Experimental Medicine, 1997
- Go-protein α-Subunits Activate Mitogen-activated Protein Kinase via a Novel Protein Kinase C-dependent MechanismJournal of Biological Chemistry, 1996
- Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor.The Journal of Experimental Medicine, 1994
- Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: Dissociation between lipid remodeling and adhesionJournal of Cellular Physiology, 1990
- Cyclical binding, processing, and functional interactions of neutrophils with leukotriene B4Journal of Cellular Physiology, 1990
- Degranulation, membrane addition, and shape change during chemotactic factor-induced aggregation of human neutrophils.The Journal of cell biology, 1982